Celanese Corporation Reports Third Quarter Earnings; Exceeds Third Quarter Guidance and Raises Full Year Outlook
Celanese reported Q3 2026 net sales of $2.556 billion, up 6% year-over-year, with U.S. GAAP diluted EPS of $0.68 and adjusted EPS of $1.65, exceeding its own guidance. The company raised its full-year 2026 adjusted EPS outlook to $6.00-$6.25 and increased its free cash flow guidance to $750-$800 million, citing productivity gains, portfolio actions, and deleveraging progress toward ~4.7x net debt-to-operating EBITDA by year end.
Key figures
- Eps
- 0.68
- Revenue
- 2556
- Guidance
- FY2026 adjusted EPS of approximately $6.00 to $6.25; free cash flow outlook increased to $750-$800 million; expects ~4.7x net debt-to-operating EBITDA at year end
- Adjusted eps
- 1.65
- Net debt musd
- 10183
- Adjusted ebit musd
- 367
- Free cash flow musd
- 461
- Operating ebitda musd
- 548
- Operating profit musd
- 198
- Fye2025 net sales musd
- 9544
- Acetyl chain sales musd
- 1209
- Operating cash flow musd
- 538
- Acetyl chain sales yoy pct
- 14
- Operating ebitda margin pct
- 21.4
- Engineered materials sales musd
- 1368
AI analysis
Red flags4 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.